101 – 110 of 2664
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma proteins defending infected, intact nasal mucosa
(
- Contribution to journal › Letter
-
Mark
Reply to “Comment on aortic size predicts aortic dissection in Turner syndrome - A 25-year prospective cohort study” by Salman Khazaei
(
- Contribution to journal › Letter
-
Mark
Authors' response
(
- Contribution to journal › Letter
-
Mark
Removing obstacles to AM should still be the focus : a reply to Dickie et al.
(
- Contribution to journal › Letter
-
Mark
Commentary on "Fatal cardiac air embolism after CT-guided percutaneous needle lung biopsy medical complication or medical malpractice?"
2023) In Forensic science, medicine, and pathology(
- Contribution to journal › Letter
-
Mark
‘Proactive aging’ is a new research approach for a new era
(
- Contribution to journal › Letter
-
Mark
Commentary on : Beer T, Bäckström B, Ottosson A, Rietz A, Michard J-F, Loisel J, et al. The utility of histology in assessing the cause of death in medico-legal autopsies in selected trauma deaths: Suspension-, immersion-, fire-, and traffic-related. J Forensic Sci. doi: 10.1111/1556-4029.15193. Epub 2023 Jan 16
(
- Contribution to journal › Letter
-
Mark
Comment to “Efficacy of basic body awareness therapy on functional outcomes : A systematic review and meta-analysis of randomized controlled trials”, published in Physiotherapy Research International in September 2022 by the authors Davy Vancampfort, Emanuel Brunner, Tine Van Damme and Brendon Stubbs
(
- Contribution to journal › Letter
-
Mark
Re : Laura S. Mertens, Richard P. Meijer, J. Alfred Witjes. Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.017
(
- Contribution to journal › Letter
-
Mark
Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
(
- Contribution to journal › Letter